Viewing Study NCT06371534


Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2025-12-27 @ 11:44 PM
Study NCT ID: NCT06371534
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module